Processing delay

Processing delay has been studied in 1 paper since 2023: 1 observational study in people. The newest paper, Jan 1, 2023: “Pre-Analytical Variables Influencing Stability of Blood-Based Biomarkers of Neuropathology”.

Exposure

1 paper studies it5 findingsUpdated

See all 1 papers on processing delay

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“Aβ40 and Aβ42 levels significantly decreased after a 24-h processing delay in both plasma and serum samples”
Pre-Analytical Variables Influencing Stability of Blood-Based Biomarkers of NeuropathologyJournal of Alzheimer's disease : JAD2023doi:10.3233/jad-230384

2 of its findings point the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • 2 findings against
  • Funders: National Institute on Aging and 1 more
  • Humans1

What did studies of processing delay find?

3

Studies of processing delay measured 3 outcomes: phosphorylated tau 181, amyloid-beta 42/40 ratio and amyloid-beta 42.

Phosphorylated tau 181

no changein humans1upin humans1

1 study
  1. Processing delay was not clearly linked with phosphorylated tau 181 in humans.

    “Plasma p-tau-181 levels notably increased with a 24-, 48-, and 72-h processing delay, but remained stable in serum.”

    HumansSerum24, 48, and 72 hoursn = 41

    Pre-Analytical Variables Influencing Stability of Blood-Based Biomarkers of Neuropathology

    Journal of Alzheimer's disease : JAD

  2. Processing delay is linked with higher phosphorylated tau 181 in humans.

    “Plasma p-tau-181 levels notably increased with a 24-, 48-, and 72-h processing delay, but remained stable in serum.”

    HumansPlasma24, 48, and 72 hoursn = 41

    Pre-Analytical Variables Influencing Stability of Blood-Based Biomarkers of Neuropathology

    Journal of Alzheimer's disease : JAD

More on Phosphorylated tau 181

Amyloid-beta 42/40 ratio

upin humans1no changein humans1

1 study
  1. Processing delay is linked with higher amyloid-beta 42/40 ratio in humans.

    “plasma Aβ42/40 ratio showed only small but significant increase with a delay up to 72 h.”

    HumansPlasmaUp to 72 hoursn = 41

    Pre-Analytical Variables Influencing Stability of Blood-Based Biomarkers of Neuropathology

    Journal of Alzheimer's disease : JAD

  2. Processing delay was not clearly linked with amyloid-beta 42/40 ratio in humans.

    “serum Aβ42/40 ratio remained stable with a processing delay up to 48 h”

    HumansSerumUp to 48 hoursn = 41

    Pre-Analytical Variables Influencing Stability of Blood-Based Biomarkers of Neuropathology

    Journal of Alzheimer's disease : JAD

More on Amyloid-beta 42/40 ratio

Amyloid-beta 42

downin humans1

1 study
  1. Processing delay is linked with lower amyloid-beta 42 in humans (Processing delay).

    “Aβ40 and Aβ42 levels significantly decreased after a 24-h processing delay in both plasma and serum samples”

    HumansProcessing delayPlasma and serum24 hoursn = 41

    Pre-Analytical Variables Influencing Stability of Blood-Based Biomarkers of Neuropathology

    Journal of Alzheimer's disease : JAD

More on Amyloid-beta 42

Latest